Netscientific Share Discussion Threads

[rk23] 05/6/2020 11:07

For the same reason they didnt buy when they were below 1p

[topnotch] 05/6/2020 09:48

HELLAVA SPREAD!!!

As the bishop said to the actress...

OMG someone bought 100K @ 10p - why didn't they buy @ 7p earlier this week???

[the stigologist] 05/6/2020 09:47

Of my 20p SOTP PDSB whilst exciting is only fraction of valuation

We need update news on ProAxsis and Glycotest

[escapetohome] 05/6/2020 09:22

Well , i succeeded in one account.

Then i went to my isa to do the same.

I was unlucky , the price had already risen , and my trade was rejected.

So lucky but not so lucky.

[investordave] 05/6/2020 09:21

And good timing too!

[investordave] 05/6/2020 09:15

A wise man at the current price.

[escapetohome] 05/6/2020 09:11

I had a small foray into this this morning.

[investordave] 05/6/2020 08:12

Not much interest here it would seem. Not even one trade so far. Perhaps it's better for the company to keep under the radar for the time being.

[investordave] 05/6/2020 07:35

Thanks. So hopefully the news is not yet priced in anywhere.

[rk23] 05/6/2020 07:32

Posted after hours, 21:05 state time

[investordave] 05/6/2020 07:26

Do we know when this news was released in the US? Was it after hours their time? Or pre closing, in which case it'll already be in the PDSB share price, which didn't change much?

[baz9707] 05/6/2020 05:22

More trials to follow looking exciting.

[rk23] 04/6/2020 22:19

PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Adv...Source: GlobeNewswire Inc.PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology, today announced a Phase 2 clinical trial to evaluate its lead immunotherapy product, PDS0101, in combination with standard of care chemoradiotherapy for treatment of locally advanced cervical cancer.The clinical trial will be conducted at The University of Texas MD Anderson Cancer Center and the Lyndon B. Johnson Hospital in Houston by Ann H. Klopp, M.D., Ph.D., Associate Professor of Radiation Oncology and Olsi Gjyshi, M.D., Ph.D. The clinical trial will investigate the safety and anti-tumor efficacy of the PDS0101-chemoradiation combination, and their correlation with critical biomarkers of an immune response in patients with locally advanced cervical cancer. On September 19, 2019, PDS Biotech announced the results of a PDS0101 Phase 1 clinical study in cervical neoplasia (pre-cervical cancer) patients. PDS0101 is being developed to treat multiple cancers associated with HPV infection, including anal, cervical and head and neck cancers. In the Phase 1 study, PDS0101 demonstrated potent in vivo induction of active killer T-cells that target cancer cells containing the cancer-causing HPV proteins, as well as an excellent safety profile with no limiting toxicities. Treatment with PDS0101 resulted in complete lesion regression in most of the patients. HPV infection is responsible for over 99% of cervical cancers. PDS Biotech currently anticipates initiating this clinical study within a few months."We are pleased to announce this Phase 2 clinical trial being performed to further validate our novel Versamune®-based immunotherapy platform and lead asset PDS0101," said Dr. Frank Bedu-Addo, CEO of PDS Biotech. "We look forward to investigating PDS0101 as a potentially safe and effective immunotherapeutic combination with standard of care chemoradiotherapy to improve the treatment options for women with locally advanced cervical cancer."

[wolves_boy] 04/6/2020 15:37

All aboard the PDSB train, chooo chooo

[baz9707] 04/6/2020 15:17

Doesn't take much to move this up.
10p should come nice a steady.

[baz9707] 03/6/2020 07:31

Netscientific has 3 valuable PF companies:
PDSB - 3 cancer clinical trials, Covid vaccine.
Glycotest - 10m funding for 50%
ProAxsis - Looking at cash break even massive rise in sales.

Board looking to deliver shareholder value.

$PDSB has gone up nearly 100% in the last month and waiting for the go ahead for phase 2 trials on a #Covid_19 vaccine.

[baz9707] 28/5/2020 18:27

PDSB rocking in the US
Hint of Covid PR will and it will fly.
100m company in the making just in the cancer treatment it has in phase 2 trials.
Great news for NSCI

[topnotch] 27/5/2020 14:32

Are we expecting any RNS stateside today????

[investordave] 22/5/2020 15:17

Or down again. NSCI rarely fails to disappoint.

[0sumgame] 22/5/2020 14:38

https://www.bbc.co.uk/news/health-52754280

[0sumgame] 22/5/2020 13:59

Should move up soon

[investordave] 22/5/2020 12:10

Err? Why the hell is the share price down today with all these buys? MMs playing games again?

[barnetpeter] 21/5/2020 17:53

PDSB looking strong up 21 per cent.

[baz9707] 21/5/2020 16:58

Would be exciting to hold NSCI if PDSB get to human testing.
Swings are crazy on news but that would be another level.

[investordave] 21/5/2020 16:52

I really don't understand some people. I would be surprised if most of them have made anything other than a very small profit, if that. Why bother, when the potential gains at stake are so significant?